Reflect Scientific, Inc.
RSCF
$0.04
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.26% | 374.36% | 77.85% | -60.58% | 107.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.26% | 374.36% | 77.85% | -60.58% | 107.70% |
| Cost of Revenue | -4.95% | 262.28% | 64.61% | -59.08% | 60.31% |
| Gross Profit | -0.67% | 492.73% | 89.65% | -62.49% | 151.91% |
| SG&A Expenses | -6.04% | 8.35% | 2.08% | 13.16% | -3.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.79% | 61.11% | 20.64% | -24.42% | 15.14% |
| Operating Income | 22.62% | 154.37% | 72.60% | -258.24% | 160.74% |
| Income Before Tax | 27.46% | 160.29% | 78.35% | -253.02% | 164.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.35% | 160.19% | 78.35% | -253.02% | 164.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.35% | 160.19% | 78.35% | -253.02% | 164.45% |
| EBIT | 22.62% | 154.37% | 72.60% | -258.24% | 160.74% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 30.00% | 161.90% | 76.47% | -257.14% | 162.50% |
| Normalized Basic EPS | 33.33% | 161.54% | 81.82% | -220.00% | 160.00% |
| EPS Diluted | 30.00% | 161.90% | 76.47% | -928.57% | 162.50% |
| Normalized Diluted EPS | 33.33% | 161.54% | 81.82% | -220.00% | 160.00% |
| Average Basic Shares Outstanding | 0.53% | 0.53% | 0.53% | 0.27% | 0.26% |
| Average Diluted Shares Outstanding | 0.00% | 0.53% | 0.53% | 0.27% | 0.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |